Cellix Expands European Network to Germany

Oct. 7, 2009 - PRLog -- Cellix Ltd announced a distribution agreement with the German based company, Chromaphor Analysen-Tecknik. Chromaphor will handle sales and service agreements for Cellix products in Germany.

“We selected Chromaphor as our distribution partner in Germany because of their proven sales methods,” explained Vivienne Williams, CEO, Cellix. “Chromaphor has exceptional insights into the cell biology markets and a customer base that is an ideal fit for our products.”

Chromaphor is a leading provider of innovative scientific products to researchers in the life science markets. With a focus on understanding customer applications and requirements, Chromaphor invests heavily in providing first-class technical and service support as well as an efficient sales process.

“We are very excited about bringing Cellix’s unique products to our customers in Germany,” stated Hugo Ostermann, Managing Director of Chromaphor. “The VenaFluxTM Platform and accessories provides exciting new tools for our customers and fits very well with our existing product portfolio”

About Chromaphor
disney cartoon characters, xbox 360, confidentiality agreement template download

Chromaphor was founded in 1995 as a distributor and systems integrator for innovative scientific instruments, reagents and accessories for the life sciences market. The focus is now on microscopy imaging and chromatography and represents international players within Europe.

About Cellix Ltd
Cellix Ltd. is a privately held instrumentation and cell-based assay company developing technologies that accurately mimic in vivo human blood vessels under physiological flow for cell-based screening in drug discovery. The Company is headquartered in Dublin, Ireland, and maintains offices in New York City. For further information visit www.cellixltd.com.

For additional information on this release, please contact:
Marketing Department
Phone: 00 353 1 896 27 99
Contact: Rachel Ashe, Marketing Executive

# # #

Cellix is an Irish company thats has developed a microfluidic drug screening tool currently being used by over a third of the top ten pharmaceutical companies worldwide.

By operating under continuous blood flow conditions, the Cellix platform simulates the human environment providing researchers with powerful data far beyond that available via the static conditions of the petri dish before advancing to costly animal trials. By using our solution, false leads can be eliminated earlier in the process, increasing the success rate of clinical trials and giving you the competitive edge.

Our solution is unique and contains everything a researcher requires to execute continuous flow cell based assays and make informed decisions. The only fully integrated end-to-end Microfluidics system on the market, the Cellix solution includes the platform, biochips and cell analysis software.